Adicet Bio, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Adicet Bio, Inc. (ACET) reported Adjustments to Additional Paid in Capital, Warrant Issued of $22.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-05
- Adicet Bio, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-06-30 was $22.00K.
- Adicet Bio, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-03-31 was $6.30M.
- Adicet Bio, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $5.20M, a 17.46% decline from fiscal 2024.
- Adicet Bio, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $6.30M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2026-06-30 | $22.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $5.20M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $6.30M 10-K · filed 2026-03-12 | |
| 2024-03-31 | $6.30M 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |